1. Short title This Act may be cited as the Affordability is Access Act of 2023 . 2. Purpose The purpose of this Act is to ensure timely access to affordable birth control by requiring coverage without cost-sharing for contraceptives that are approved, granted, or cleared by, or otherwise legally marketed under regulation by, the Food and Drug Administration for use without a prescription. 3. Findings The Senate finds the following: (1) Birth control is critical health care that almost all women, as well as many trans men and nonbinary people, will use at some point in their lifetimes. (2) Access to the full range of reproductive health care, including birth control coverage as guaranteed under Federal law, provides individuals with the opportunity to lead healthy lives and get the care they need to reach their goals. (3) Contraceptive access is associated with health benefits for women, newborns, families, and communities and can lower the risk of harm to maternal and infant health. (4) An estimated 73 million women of reproductive age (ages 15 through 49) live in the United States. Among the 46 million of such women who are sexually active and not seeking children, 89 percent use a form of birth control. (5) The birth control benefit enacted under the Patient Protection and Affordable Care Act ( Public Law 111–148 ) has been a crucial step forward in advancing access to birth control and has helped ensure 58 million women have the power to decide for themselves if and when to become pregnant. (6) Despite legal requirements for birth control coverage and access to services, gaps remain for millions of individuals. Nearly 1 in 5 women are not using their preferred method of contraception, and of those women, a quarter say it is because of cost. As a result, many women have gone without the birth control they want to use, also creating inconsistent use. Access to birth control is particularly difficult for the 19 million women of reproductive age with lower incomes who live in contraceptive deserts and lack